Aprea Therapeutics Inc (APRE) — Institutional Holders Breakdown (Q2 2026)

APRE ranks #7554 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

APRE is a disclosed holding of Jim Simons (Renaissance Technologies), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

29 institutions disclose a position in APRE, but none treat it as a major bet — even AIGH Capital Management LLC, its most concentrated holder, allocates just 0.1% of its own portfolio to it.

AIGH Capital Management LLC has added to its APRE position for two straight quarters, increasing it by $498.7K to reach $814.8K today.

LPL Financial LLC has trimmed its APRE position for two straight quarters, cutting it by $9.3K while still holding $12.9K.

APRE reported a net loss of $12.6M in its latest fiscal year.

• Not yet profitable — net loss of $12.6M in the latest fiscal year
• Revenue declined 81.0% year over year
• Net income improved year over year, from -$13.0M to -$12.6M
• Operating cash flow was negative, using $12.9M in cash
• Current ratio of 5.63x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.28x equity — within a conventional range